Effect of change in renal replacement therapy modality on laboratory variables: A cohort study from the UK Renal Registry

Nephrology Dialysis Transplantation

Volumn 24, Issue 9, 2009, Pages 2877-2882

  Rao, Raman ^a   Ansell, David ^a   Gilg, Julie A ^a   Davies, Simon J ^b   Lamb, Edmund J ^c   Tomson, Charlie R V ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

Haemodialysis; Kidney transplantation; Laboratory variables; Modality change; Peritoneal dialysis

Indexed keywords

ALBUMIN; BICARBONATE; CALCIUM; CHOLESTEROL; FERRITIN; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL; UNITED KINGDOM;

ADULT; AGED; BICARBONATES; CALCIUM; CHOLESTEROL; COHORT STUDIES; FEMALE; FERRITINS; GREAT BRITAIN; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARATHYROID HORMONE; PERITONEAL DIALYSIS; PHOSPHATES; REGISTRIES; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; SERUM ALBUMIN;

EID: 69249123224     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp163     Document Type: Article

References (29)

1. Farrington K, Rao R, Gilg J New adult patients starting renal replacement therapy in the UK in 2005 (chapter 3). Nephrol Dial Transplant2007; 22(Suppl 7): vii11-vii29
2. Richardson D, Hodsman A, van Schalkwyk D et al. Management of anaemia in haemodialysis and peritoneal dialysis patients (chapter 8). Nephrol Dial Transplant 2007; 22(Suppl 7): vii78-vii104
3. Lamb EJ, Hodsman A, van Schalkwyk D et al. Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (chapter 9). Nephrol Dial Transplant 2007; 22(Suppl 7): vii105-vii118
4. Hodsman A, Feest T, Ansell D, et al. The UK Renal Registry: what makes it different from other national registries? Br J Renal Med 2007; 12: 28-31
5. Tomson C, Ford D, Ansell D. The UK Renal Registry: an overview. Br J Hosp Med (Lond) 2008; 69: 548-549
6. Brossard JH, Cloutier M, Roy L et al. Accumulation of a non-(1-84) molecular formof parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996; 81: 3923-3929
7. Maguire GA, Price CP. Bromcresol purple method for serum albumin gives falsely lowvalues in patients with renal insufficiency. Clin Chim Acta 1986; 155: 83-87
8. Carfray A, Patel K, Whitaker P et al. Albumin as an outcome measure in haemodialysis in patients: the effect of variation in assay method. Nephrol Dial Transplant 2000; 15: 1819-1822
9. Wells FE, Addison GM, Postlethwaite RJ. Albumin analysis in serum of haemodialysis patients: discrepancies between bromocresol purple, bromocresol green and electroimmunoassay. Ann Clin Biochem 1985; 22(Pt 3): 304-309
10. Ansell D, Feest T. UK Renal Registry Report 2000. Bristol: UK Renal Registry, 2000. Available at http://www.renalreg.com/Report% 202000/Cover-2000-Frame.htm(updated 2000; cited)
11. Suzuki T, Kanno Y, Nakamoto H et al. Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism. Adv Perit Dial 2003; 19: 148-154
12. UK Renal Registry. The seventh UK Renal Registry Report, 2004. Chapter 4: all patients receiving renal replacement therapy in the United Kingdom in 2003, Bristol, 2004
13. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 2002; 61: 655-667
14. Schaubel DE, Blake PG, Fenton SS. Trends in CAPD technique failure: Canada, 1981-1997. Perit Dial Int 2001; 21: 365-371
15. Maiorca R, Vonesh EF, Cavalli P et al. A multicenter, selectionadjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11: 118-127
16. Jindal KK, Hirsch DJ.Excellent technique survival on home peritoneal dialysis: results of a regional program. Perit Dial Int 1994; 14: 324- 326
17. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997; 17: 360-364
18. Coronel F, Herrero JA, Montenegro J et al. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis. J Nephrol 2003; 16: 697-702
19. Snyder JJ, Foley RN, Gilbertson DT et al. Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States. J Am Soc Nephrol 2004; 15: 174-179
20. UK Renal Registry. UK Renal Registry 7th Annual Report 2004: Chapter 8: factors influencing haemoglobin, Bristol, 2004; Available at www.renalreg.org(updated 2004; cited)
21. Blagg CR, Liedtke RJ, Batjer JD et al. Serum albumin concentrationrelated Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis1993; 21: 138-144
22. Clase CM, St Pierre MW, Churchill DN. Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant 2001; 16: 1925-1929
23. Malberti F, CorradiB, Imbasciati E. Effect ofCAPDand hemodialysis on parathyroid function. Adv Perit Dial 1996; 12: 239-244
24. Torres A, Lorenzo V, Hernandez D et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 1995; 47: 1434-1442
25. Malberti F, Corradi B, Pagliari B et al. The sigmoidal parathyroid hormone-ionized calcium curve and the set point of calcium in hemodialysis and continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): S476-S479
26. Kurz P, Tsobanelis T, Roth P et al. Differences in calcium kinetic pattern between CAPD and HD patients. Clin Nephrol 1995; 44: 255- 261
27. Murray TM, Rao LG, Divieti P et al. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 2005; 26: 78-113
28. Rayner HC, Pisoni RL, Bommer J et al. Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 108-120
29. Ansell D, Udayaraj UP, Steenkamp R et al. Chronic renal failure in kidney transplant recipients. Do they receive optimum care? Data from the UK Renal Registry. Am J Transplant 2007; 7: 1167-1176